Lipoprotein (a) levels and clinical decision-making: data from a Mexican cohort at a tertiary medical institution
Lp(a) testing was infrequent in a tertiary medical setting. Clinical interventions to modify cardiovascular risk factors were insufficient among patients with elevated Lp(a). These findings highlight the need for greater awareness among healthcare providers and the development of comprehensive screening and management algorithms to mitigate Lp(a) -related cardiovascular risk.
Authors
- Carlos Alberto Aguilar-Salinas (ORCID: https://orcid.org/0000-0001-8517-0241)
- Daniel Elías-López (ORCID: https://orcid.org/0000-0001-9817-409X)
- Ivette Cruz‐Bautista (ORCID: https://orcid.org/0000-0002-2391-6367)
- Adrián Soto-Mota (ORCID: https://orcid.org/0000-0002-9173-7440)
- Sonia Luna del Villar Velasco
- Raymundo David Valdez-Echeverría (ORCID: https://orcid.org/0000-0003-2876-3897)
- Roopa Mehta (ORCID: https://orcid.org/0000-0002-2509-8054)
- Arsenio Vargas‐Vázquez (ORCID: https://orcid.org/0000-0002-0051-7689)
- Guillermo Enrique Chan-Puga
- Mario Morales-Esponda (ORCID: https://orcid.org/0009-0007-8999-576X)
- Linda Liliana Muñóz-Hernández (ORCID: https://orcid.org/0000-0003-2803-4408)
- Sandra Rosales-Uvera
- Yuscely Flores-Jurado (ORCID: https://orcid.org/0000-0002-0798-2989)
- Misael Aguilar-Panduro (ORCID: https://orcid.org/0009-0003-4094-3273)
- Guillermo Roa-Álvarez
- Mariana Salas-Aldana
- Ricardo Federico Hernández-Franco
Institutions
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
- Universidad Del Valle De Cuernavaca (MX)
- Tecnológico de Monterrey (MX)
Publication Details
- Journal
- Lipids in Health and Disease
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1186/s12944-025-02610-w
- Citations
- 4
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 8.03